William Blair Upgrades Natus Medical (BABY) to Outperform
More News related to BABY
- natus Medical (BABY) Posts Q3 EPS of $0.13, Tops by 2c; Guides
- Natus Medical Announces 2009 Third Quarter Financial Results and Increases Fourth Quarter and Full Year 2009 Guidance
- Natus Medical to Hold 2009 Third Quarter Financial Results Conference Call on November 2
- Cowen & Co Upgrades Natus Medical (BABY) to Outperform
- Notable Mergers and Acquisitions of the Day 9/14: S/DT, CA, BABY
More News related to Upgrades
- Keefe, Bruyette & Woods Upgrades Capstead Mortgage (CMO) to Outperform; Valuation Call
- RadioShack (RSH) iPhone News is a Game-Changer
- Wedbush Upgrades Perma-Fix Environmental Services (PESI) to Outperform; Adjusts PT & Estimates
- JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight
- Leerink Swann Upgrades Merck & Co (MRK) to Outperform; Near-Term Risks Already Factored In
William Blair upgrades Natus Medical (Nasdaq: BABY) from Market Perform to Outperform.
Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Related Categories
UpgradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
